Department of Pediatrics, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Pediatr Rheumatol Online J. 2012 May 2;10(1):12. doi: 10.1186/1546-0096-10-12.
Children represent 10-20% of all systemic lupus erythematosus (SLE) patients. Their clinical manifestations and outcomes vary with age. We aim to clarify the relationship between pubescent status and the clinical manifestations of pediatric SLE.
In this study, pediatric SLE patients were divided into three groups, based on age at disease onset (≦8, 8-13 & 13-18 years), defined as prepubescent, pubescent and postpubescent, respectively. Initial clinical manifestations and laboratory characteristics at diagnosis were analyzed.
Ninety-six patients were entered into the study: 8 had disease onset before age 8, while 49 were between 8-13 and 39 of them were 13-18. Female predominance was noted in all three groups (2.5-7.0:1). Postpubescents showed significantly more renal involvement and lymphopenia, along with lower levels of C3 and C4, when compared with prepubescents. They also showed significantly more lymphopenia when compared with pubescents. Pubescents showed significantly more renal involvement, leukopenia and lupus anticoagulant (LAC) positivity, along with lower C3 and C4 levels, when compared with prepubescents. Pubescents also showed significantly higher anti-Sm antibody positivity when compared with postpubescents. Prepubescents showed significantly more splenomegaly and anti-Jo-1 antibody positivity when compared with those of pubescents. The results showed that the disease activity (SLEDAI-2K score) correlated positively with age at disease onset and negatively with disease duration before diagnosis (p = 0.011).
Age at disease onset is related to initial manifestations in pediatric SLE patients at our center. Certain parameters such as renal involvement, splenomegaly, low C3 level, low C4 level, lymphopenia, leukopenia, and anti-Sm & anti-Jo-1 antibody were found to be significantly different among the age groups. Renal involvement might be the key symptom that varies with age.
儿童约占系统性红斑狼疮(SLE)患者的 10-20%。他们的临床表现和结局因年龄而异。我们旨在阐明青春期状态与儿科 SLE 临床表现之间的关系。
在这项研究中,根据疾病发病年龄(≤8 岁、8-13 岁和 13-18 岁),将儿科 SLE 患者分为三组,分别定义为青春期前、青春期和青春期后。分析诊断时的初始临床表现和实验室特征。
96 例患者入组:8 例发病年龄<8 岁,49 例发病年龄为 8-13 岁,39 例发病年龄为 13-18 岁。三组均为女性优势(2.5-7.0:1)。与青春期前组相比,青春期后组的肾脏受累和淋巴细胞减少更为明显,C3 和 C4 水平更低。与青春期前组相比,青春期后组的淋巴细胞减少更为明显。与青春期前组相比,青春期组的肾脏受累、白细胞减少和狼疮抗凝物(LAC)阳性率更高,C3 和 C4 水平更低。与青春期后组相比,青春期组的抗 Sm 抗体阳性率更高。与青春期组相比,青春期前组的脾肿大和抗 Jo-1 抗体阳性率更高。结果表明,疾病活动度(SLEDAI-2K 评分)与发病年龄呈正相关,与诊断前疾病持续时间呈负相关(p=0.011)。
发病年龄与本中心儿科 SLE 患者的初始表现有关。某些参数,如肾脏受累、脾肿大、C3 水平低、C4 水平低、淋巴细胞减少、白细胞减少以及抗 Sm 和抗 Jo-1 抗体,在不同年龄组之间存在显著差异。肾脏受累可能是随年龄变化的关键症状。